Journal of Alloys and Compounds, Journal Year: 2024, Volume and Issue: unknown, P. 177857 - 177857
Published: Nov. 1, 2024
Language: Английский
Journal of Alloys and Compounds, Journal Year: 2024, Volume and Issue: unknown, P. 177857 - 177857
Published: Nov. 1, 2024
Language: Английский
Materials Today, Journal Year: 2025, Volume and Issue: unknown
Published: March 1, 2025
Language: Английский
Citations
0Frontiers in Pharmacology, Journal Year: 2025, Volume and Issue: 16
Published: April 3, 2025
Alzheimer’s disease (AD) is one of the most common diseases characterized by neurodegeneration and becoming a major public health problem worldwide. AD manifested mainly progressive impairments in cognition, emotion, language memory elderly population. Many treatment strategies have been explored for decades; however, there still no effective way to address root cause pathogenesis, only target symptoms improve patient cognitive outcomes. Intracerebral administration difficult because challenges posed blood‒brain barrier (BBB). NPs are materials with sizes between 1 100 nm that can biocompatibility, extend half-life, transport macromolecules, be delivered across BBB central nervous system, exhibit good targeting capabilities. provide new ideas terms their antiaging, antineuroinflammatory, antioxidative, nerve repair-promoting effects. In this manuscript, we first describe relationship BBB. Second, introduce application nanoparticles treatment. Finally, summarize faced AD.
Language: Английский
Citations
0Journal of Alloys and Compounds, Journal Year: 2024, Volume and Issue: unknown, P. 177857 - 177857
Published: Nov. 1, 2024
Language: Английский
Citations
1